Ellefsen Kayla N, da Costa Jose Luiz, Concheiro Marta, Anizan Sebastien, Barnes Allan J, Pirard Sandrine, Gorelick David A, Huestis Marilyn A
Chemistry & Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Program in Toxicology, University of Maryland Baltimore, Baltimore, MD 21201, USA.
Bioanalysis. 2015;7(16):2041-56. doi: 10.4155/bio.15.127.
DBS are an increasingly common clinical matrix.
METHODS & RESULTS: Sensitive and specific methods for DBS and venous blood cocaine and metabolite detection by LC-HRMS and 2D GC-MS, respectively, were validated to examine correlation between concentrations following controlled intravenous cocaine administration. Linear ranges from 1 to 200 µg/l were achieved, with acceptable bias and imprecision. Authentic matched specimens' (392 DBS, 97 venous blood) cocaine and benzoylecgonine concentrations were qualitatively similar, but DBS had much greater variability (21.4-105.9 %CV) and were lower than in blood.
DBS offer advantages for monitoring cocaine intake; however, differences between capillary and venous blood and DBS concentration variability must be addressed.
干血斑是一种越来越常见的临床样本。
分别通过液相色谱-高分辨质谱法(LC-HRMS)和二维气相色谱-质谱法(2D GC-MS)验证了用于检测干血斑及静脉血中可卡因及其代谢物的灵敏且特异的方法,以研究静脉注射可卡因后血药浓度之间的相关性。实现了1至200μg/l的线性范围,偏差和不精密度均可接受。真实匹配样本(392份干血斑、97份静脉血)中的可卡因和苯甲酰爱康宁浓度在定性上相似,但干血斑的变异性更大(变异系数21.4 - 105.9%)且低于血液中的浓度。
干血斑在监测可卡因摄入量方面具有优势;然而,必须解决毛细血管血与静脉血之间的差异以及干血斑浓度变异性问题。